These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11859947)

  • 21. Cutaneous side effects of medium dose methotrexate in children with acute lymphoblastic leukaemia.
    van den Bos C; Bierings MB; Bruin MC; Rademaker CM; van Haselen CW; Révész T
    Med Pediatr Oncol; 2000 Apr; 34(4):278-80. PubMed ID: 10742071
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyogenic granuloma-like lesions during capecitabine therapy.
    Piguet V; Borradori L
    Br J Dermatol; 2002 Dec; 147(6):1270-2. PubMed ID: 12452889
    [No Abstract]   [Full Text] [Related]  

  • 23. Cutaneous vasculitis associated with gemcitabine therapy.
    Corella F; Dalmau J; Roé E; García-Navarro X; Alomar A
    Clin Exp Dermatol; 2009 Jan; 34(1):97-9. PubMed ID: 19076809
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hand-foot syndrome with capecitabine therapy].
    Marini A; Hengge UR
    Hautarzt; 2007 Jun; 58(6):532-6. PubMed ID: 16897045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
    Curtis S; Hong S; Gucalp R; Calvo M
    Am J Ther; 2016; 23(1):e321-3. PubMed ID: 24451298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases.
    Brandes A; Reichmann U; Plasswilm L; Bamberg M
    Anticancer Drugs; 2000 Jan; 11(1):15-7. PubMed ID: 10757558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyogenic granuloma-like lesions caused by capecitabine therapy.
    Piqué-Duran E; Pérez-Díaz MJ; Pérez-Cejudo JA
    Clin Exp Dermatol; 2008 Aug; 33(5):652-3. PubMed ID: 18616732
    [No Abstract]   [Full Text] [Related]  

  • 28. Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
    Attar EC; Ervin T; Janicek M; Deykin A; Godleski J
    J Clin Oncol; 2000 Feb; 18(3):697-8. PubMed ID: 10653887
    [No Abstract]   [Full Text] [Related]  

  • 29. Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.
    Lee SD; Kim HJ; Hwang SJ; Kim YJ; Nam SH; Kim BS
    Korean J Intern Med; 2007 Jun; 22(2):109-12. PubMed ID: 17616027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe acute lung injury induced by gemcitabine.
    Linskens RK; Golding RP; van Groeningen CJ; Giaccone G
    Neth J Med; 2000 Jun; 56(6):232-5. PubMed ID: 10821980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine-associated sweet syndrome-like eruption.
    Martorell-Calatayud A; Requena C; Sanmartin O; Balmer N; Guillen-Barona C
    J Am Acad Dermatol; 2011 Dec; 65(6):1236-8. PubMed ID: 22082849
    [No Abstract]   [Full Text] [Related]  

  • 32. Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer.
    Chen YM; Liu JM; Tsai CM; Whang-Peng J; Perng RP
    J Clin Oncol; 1996 May; 14(5):1743-4. PubMed ID: 8622097
    [No Abstract]   [Full Text] [Related]  

  • 33. Linear immunoglobulin A bullous dermatosis induced by gemcitabine.
    del Pozo J; Martínez W; Yebra-Pimentel MT; Almagro M; Peña-Penabad C; Fonseca E
    Ann Pharmacother; 2001; 35(7-8):891-3. PubMed ID: 11485141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blisters unlike others].
    Gugerli O; Leupin N
    Rev Med Suisse; 2006 Apr; 2(62):1076-7. PubMed ID: 16711153
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
    Risum S; Langer SW
    Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
    Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gemcitabine-cisplatin combination in the first line treatment of non-small cell lung cancer. Our experience and analysis of safety].
    Sárosi V; Lénárt T
    Magy Onkol; 2003; 47(2):189-93. PubMed ID: 12975668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine.
    Laack E; Mende T; Knuffmann C; Hossfeld DK
    Ann Oncol; 2001 Dec; 12(12):1761-3. PubMed ID: 11843256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.